Patent 7125858 was granted and assigned to Bioniche Life Sciences Inc. on October, 2006 by the United States Patent and Trademark Office.
The present invention relates to a composition and method comprising purified HA, a second anti-neoplastic agent and a pharmaceutically acceptable carrier, wherein the purified HA and the second anti-neoplastic agent are administered to a mammal having cancer in an amount effective to treat the cancer.